Additional Proxy Soliciting Materials (definitive) (defa14a)
26 April 2022 - 06:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the
Registrant ¨
Check the appropriate box:
¨ Preliminary
Proxy Statement
¨ Confidential,
for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
¨ Definitive
Proxy Statement
þ Definitive
Additional Materials
¨ Soliciting
Material Pursuant to § 240.14a-12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AVALO THERAPEUTICS, INC.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
|
|
|
|
|
N/A |
|
(Name of Person(s) Filing Proxy Statement if Other Than the
Registrant)
|
Payment of Filing Fee (Check the appropriate box)
þ No
fee required.
¨ Fee
paid previously with preliminary materials.
¨ Fee
computed on table in exhibit required by Item 25(b) per Exchange
Act Rules 14a-6(i)(1) and 0-11.
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From May 2022 to Jun 2022
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Jun 2021 to Jun 2022
